Angiotensin receptor blocker alleviates liver fibrosis by altering the mechanotransduction properties of hepatic stellate cells | American Journal of Physiology-Gastrointestinal and Liver Physiology
Angiotensin receptors | Introduction | BPS/IUPHAR Guide to PHARMACOLOGY
The angiotensin II type 1 receptor and receptor-associated proteins | Cell Research
Vascular and cardiac benefits of angiotensin receptor blockers - The American Journal of Medicine
A Novel Mechanism of Action for Angiotensin-(1–7) via the Angiotensin Type 1 Receptor | Hypertension
Sex differences in the metabolic effects of the renin-angiotensin system | Biology of Sex Differences | Full Text
Reassessment of the Unique Mode of Binding between Angiotensin II Type 1 Receptor and Their Blockers | PLOS ONE
ACE Inhibitors versus AT1 Receptor Antagonists in Patients with Chronic Renal Disease | American Society of Nephrology
Immunologic Effects of the Renin-Angiotensin System | American Society of Nephrology
Angiotensin converting enzyme inhibitors and angiotensin receptor blockers - BJA Education
Renin-Angiotensin System and Angiotensin Receptor Blockers in the Metabolic Syndrome | Circulation
Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19 | NEJM
Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention - International Journal of Cardiology
Renin–angiotensin system blockers and susceptibility to COVID-19: an international, open science, cohort analysis - The Lancet Digital Health
![IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1–7]) and Decreases Blood Pressure in Obese Individuals | Hypertension](https://www.ahajournals.org/cms/asset/c514bc66-af77-4759-b7f9-1503e4f6084b/hypertensionaha.119.13982.fig04.jpg "IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1–7]) and Decreases Blood Pressure in Obese Individuals | Hypertension")
IL (Interleukin)-1 Receptor Antagonist Increases Ang (Angiotensin [1–7]) and Decreases Blood Pressure in Obese Individuals | Hypertension
What is the ACE2 receptor, how is it connected to coronavirus and why might it be key to treating COVID-19? The experts explain
Angiotensin II and inflammation: the effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockade | Journal of Human Hypertension
Should Angiotensin-Converting Enzyme Inhibitors ever Be Used for the Management of Hypertension? | SpringerLink
Figure 1, Different mechanisms of pharmacological blockade of the renin- angiotensin system - Comparative Effectiveness Review Summary Guides for Clinicians - NCBI Bookshelf
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
Angiotensin II suppression in SARS-CoV-2 infection: a therapeutic approach | Nefrología
ACEI/ARB therapy in COVID-19: the double-edged sword of ACE2 and SARS-CoV-2 viral docking | Critical Care | Full Text
Angiotensin Receptor Antagonist - an overview | ScienceDirect Topics
Frontiers | Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
Ganging up on Angiotensin II Type 1 Receptors in Vascular Remodeling | Hypertension
Sartan Derivative - an overview | ScienceDirect Topics
